27
Aug
2024

Nanjing Lifenergy R&D Co., Ltd

Exhibitor at CPHI Korea 2024 stand G33
About Us

A high-tech pharmaceutical company, specialized in R&D, manufacturing and marketing for pharmaceutical products focusing on the field of nephrology as well as other areas. With built-in GLP-certificated and fully-equipped modern laboratory, we have state-of-the-art scientific research background.

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • CN
  • 2015
    On CPHI since
  • 3
    Certificates
  • 250 - 499
    Employees
Company types
Manufacturer/Innovator
Primary activities
Generic APIs producer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Korea 2024
  • 27 Aug 2024 - 29 Aug 2024
  • COEX, Seoul, Korea
  • Visit us at stand G33

Products Featured at CPHI Korea 2024

  • Amphotericin B Liposome for Injection

    Product Amphotericin B Liposome for Injection

    Indications:
    Empirical therapy for presumed fungal infection in febrile, neutropenic patients;
    Treatment of cryptococcal meningitis in HIV-infected patients;
    Treatment of patients with Aspergillus species, Candida species and/or Cryptococcus species infections and treatment of visceral leishm...
  • Doxorubicin Hydrochloride Liposome Injection

    Product Doxorubicin Hydrochloride Liposome Injection

    Indications:

    Ovarian Cancer
    Doxorubicin Hydrochloride Liposome Injection is indicated for the treatment of patients with ovarian cancer whose disease has progressed or recurred after platinum-based chemotherapy.

    Multiple Myeloma
    ...